$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
恩瑞格的效果好吗?
2025-10-19 11:44:20
Check Details
地拉罗司在国内的价格
2025-10-19 11:44:20
Check Details
地拉罗司怎么买?
2025-10-19 11:44:20
Check Details
恩瑞格说明书
2025-10-19 11:44:20
Check Details
恩瑞格用法用量
2025-10-19 11:44:20
Check Details
地拉罗司哪里有卖?
2025-10-19 11:44:20
Check Details
恩瑞格适应症
2025-10-19 11:44:20
Check Details
地拉罗司适应症
2025-10-19 11:44:20
Check Details
地拉罗司的获批适应症
2025-10-19 11:44:20
Check Details
地拉罗司怎么用?
2025-10-19 11:44:20
Check Details
Deferasirox效果好吗?
2025-10-19 11:44:20
Check Details
恩瑞格的注意事项
2025-10-19 11:44:20
Check Details
1
2
3
4
5
6
7
8
9
10
...
936
937
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
2
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
3
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
4
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor
5
Ponatinib: A Third-Generation TKI Targeting BCR::ABL1 to Overcome Leukemia Drug Resistance
6
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
7
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
8
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
9
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
10
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
11
FDA Approves Subcutaneous Isatuximab (Sarclisa) for Multiple Myeloma: A New Administration Option
12
Ponatinib vs. Olverembatinib: A Multidimensional Comparison of Third-Generation BCR-ABL Inhibitors